Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Mon, 22.07.2024
MAX Automation SE
Company Name:
MAX Automation SE
ISIN:
DE000A2DA588
Reason for the research:
Update
Recommendation:
BUY
from:
22.07.2024
Target price:
EUR 8.20
Last rating change:
Analyst:
Konstantin Völk
Q2 preview // business climate expected to remain muted
Topic: MAX will release its 2nd quarter on August 2 nd . We expect sales and mar [ … ]
Mon, 22.07.2024
Dr. Ing. h.c. F. Porsche AG
Alexander Pollich takes over the CEO role at Porsche China
Stuttgart/Shanghai. On 1 September 2024 at the earliest, Alexander Pollich is moving to the Shanghai-based position of President and CEO Porsche China, Hong Kong and Macao. Over a period of more than 23 years with Porsche, Pollich has held a variety of management positions. Since 2018, he [ … ]
Mon, 22.07.2024
STEMMER IMAGING AG
Puchheim, July 22, 2024
STEMMER IMAGING AG: MiddleGround Capital concludes investment agreement with STEMMER IMAGING and announces voluntary public takeover offer at EUR 48.00 per share
Voluntary public takeover offer by MiddleGround Capital at a price of EUR 48.00 per share, which corresponds to a premium of 52% to the closing share price on Jul [ … ]
Mon, 22.07.2024
STEMMER IMAGING AG
Puchheim, July 22, 2024
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014
STEMMER IMAGING AG: MiddleGround Capital concludes investment agreement with STEMMER IMAGING and announces voluntary public takeover offer at EUR 48.00 per share
Puchheim, July 22, 2024 – MiddleGround Capital announced today its [ … ]
Mon, 22.07.2024
Eleving Group S.A.
Riga, Latvia, 22 July 2024
Eleving Group and its group companies (the "Group"), specializing in vehicle and consumer financing, cordially invite investors and analysts to an earnings call with the Management Board on 1 August 2024, 15:00 CEST, following the publication of its unaudited 6M 2024 results on 31 July 2024.
Group CEO Modestas Sudnius and [ … ]
Mon, 22.07.2024
Blitz 24-884 AG (future name: Ventrifossa BidCo AG)
EQS-WpÜG: Blitz 24-884 AG (future name: Ventrifossa BidCo AG) / Takeover Offer
Takeover Offer / Target company: STEMMER IMAGING AG; Bidder: Blitz 24-884 AG (in future: Ventrifossa BidCo AG)
22.07.2024 / 08:25 CET/CEST
Dissemination of an announcement according to the German Securities Acquisition and Takeover Act (WpÜG), transmitted by EQ [ … ]
Mon, 22.07.2024
Reinet Investments SCA
Reinet Investments Manager S.A., acting on behalf of Reinet Investments S.C.A. (the ‘Company’), is pleased to announce that the annual report (which includes the consolidated annual financial statements, the “Annual Report”) for the year ended 31 March 2024 is available for download at http://www.reinet.com/investor-relations/reports.html and at ht [ … ]
Mon, 22.07.2024
DATAGROUP SE
Pliezhausen, 22 July 2024. DATAGROUP has been awarded ‘Leader’ status in the field of ‘Managed Security Services – SOC (Midmarket)’ in the 2024 ISG Provider Lens™ report. This award underlines DATAGROUP’s comprehensive range of services in cybersecurity. With its security operations centers in Germany, DATAGROUP offers 24/7 protection and effective [ … ]
Mon, 22.07.2024
Nordex SE
169 m rotor diameter
Power rating up to 5.5 MW
Hamburg, 22 July 2024. The Nordex Group is expanding its product portfolio in the 5 MW segment and is launching a turbine variant of the proven Delta4000 platform, which is specially tailored to the requirements of the US market.
The N169/5.X has a rotor diameter of 169 meters and a power rating up t [ … ]
Mon, 22.07.2024
Spexis AG
Ad hoc announcement pursuant to Art. 53 LR
Allschwil, Switzerland, 22 July 2024
Spexis expects that audit of its 2023 financials will not be completed by 31 July 2024, provides status update relating to the Company’s moratorium and changes to its Executive Committee.
Spexis AG (SIX: SPEX), a clinical-stage biopharmaceutical company focused on m [ … ]